Biological Activities of Hydrazone Derivatives

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2007 Oct 26

PMID 17960096

Citations 163

Authors

Sevim Rollas

S Guniz Kucukguzel

Affiliations

Soon will be listed here.

Abstract

There has been considerable interest in the development of novel compounds with anticonvulsant, antidepressant, analgesic, antiinflammatory, antiplatelet, antimalarial, antimicrobial, antimycobacterial, antitumoral, vasodilator, antiviral and antischistosomiasis activities. Hydrazones possessing an azometine -NHN=CH- proton constitute an important class of compounds for new drug development. Therefore, many researchers have synthesized these compounds as target structures and evaluated their biological activities. These observations have been guiding for the development of new hydrazones that possess varied biological activities.

Citing Articles

Hydrazones, hydrazones-based coinage metal complexes, and their biological applications.

Tafere D, Gebrezgiabher M, Elemo F, Sani T, Atisme T, Ashebr T RSC Adv. 2025; 15(8):6191-6207.

PMID: 40034805 PMC: 11873977. DOI: 10.1039/d4ra07794f.

Hydrazone fluorescent sensors for the monitoring of toxic metals involved in human health from 2014-2024.

Ciupa A RSC Adv. 2025; 15(5):3465-3473.

PMID: 39906630 PMC: 11791624. DOI: 10.1039/d4ra09068c.

New quinazolone-sulfonate conjugates with an acetohydrazide linker as potential antimicrobial agents: design, synthesis and molecular docking simulations.

Kassem A, Ragab S, Omar M, Altwaijry N, Abdelraof M, Temirak A RSC Adv. 2025; 15(2):1033-1048.

PMID: 39807202 PMC: 11726445. DOI: 10.1039/d4ra07563c.

Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study.

Abdel-Aziz A, El-Azab A, Brogi S, Ayyad R, Al-Suwaidan I, Hefnawy M Int J Mol Sci. 2025; 25(24.

PMID: 39769383 PMC: 11728000. DOI: 10.3390/ijms252413621.

Evaluation of hydrazone and -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer's disease.

Bartolic M, Matosevic A, Marakovic N, Busic V, Roca S, Vikic-Topic D J Enzyme Inhib Med Chem. 2024; 39(1):2431832.

PMID: 39654394 PMC: 11633425. DOI: 10.1080/14756366.2024.2431832.

References

Savini L, Chiasserini L, Travagli V, Pellerano C, Novellino E, Cosentino S . New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity. Eur J Med Chem. 2004; 39(2):113-22. DOI: 10.1016/j.ejmech.2003.09.012. View

Cocco M, Congiu C, Lilliu V, Onnis V . Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives. Bioorg Med Chem. 2005; 14(2):366-72. DOI: 10.1016/j.bmc.2005.08.012. View

Sah P, PEOPLES S . Isonicotinyl hydrazones as antitubercular agents and derivatives for identification of aldehydes and ketones. J Am Pharm Assoc Am Pharm Assoc. 1954; 43(9):513-24. DOI: 10.1002/jps.3030430902. View

Ulgen M, Durgun B, Rollas S, Gorrod J . The in vitro hepatic microsomal metabolism of benzoic acid benzylidenehydrazide. Drug Metabol Drug Interact. 2011; 13(4):285-94. DOI: 10.1515/DMDI.1997.13.4.285. View

Kucukguzel S, Oruc E, Rollas S, Sahin F, Ozbek A . Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds. Eur J Med Chem. 2002; 37(3):197-206. DOI: 10.1016/s0223-5234(01)01326-5. View

Gemma S, Kukreja G, Fattorusso C, Persico M, Romano M, Altarelli M . Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. Bioorg Med Chem Lett. 2006; 16(20):5384-8. DOI: 10.1016/j.bmcl.2006.07.060. View

Masunari A, Tavares L . A new class of nifuroxazide analogues: synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus. Bioorg Med Chem. 2007; 15(12):4229-36. DOI: 10.1016/j.bmc.2007.03.068. View

Abadi A, Eissa A, Hassan G . Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem Pharm Bull (Tokyo). 2003; 51(7):838-44. DOI: 10.1248/cpb.51.838. View

Sinha N, Jain S, Tilekar A, Upadhayaya R, Kishore N, Jana G . Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents. Bioorg Med Chem Lett. 2005; 15(6):1573-6. DOI: 10.1016/j.bmcl.2005.01.073. View

10.

Duarte C, Tributino J, Lacerda D, Martins M, Alexandre-Moreira M, Dutra F . Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg Med Chem. 2007; 15(6):2421-33. DOI: 10.1016/j.bmc.2007.01.013. View

11.

Vicini P, Zani F, Cozzini P, Doytchinova I . Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem. 2002; 37(7):553-64. DOI: 10.1016/s0223-5234(02)01378-8. View

12.

Demirbas N, Karaoglu S, Demirbas A, Sancak K . Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives. Eur J Med Chem. 2004; 39(9):793-804. DOI: 10.1016/j.ejmech.2004.06.007. View

13.

Silva A, Zapata-Sudo G, Kummerle A, Fraga C, Barreiro E, Sudo R . Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues. Bioorg Med Chem. 2005; 13(10):3431-7. DOI: 10.1016/j.bmc.2005.03.003. View

14.

Fraga A, Rodrigues C, de Miranda A, Barreiro E, Fraga C . Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists. Eur J Pharm Sci. 2000; 11(4):285-90. DOI: 10.1016/s0928-0987(00)00102-0. View

15.

Sriram D, Yogeeswari P, Madhu K . Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones. Bioorg Med Chem Lett. 2005; 15(20):4502-5. DOI: 10.1016/j.bmcl.2005.07.011. View

16.

Durgun B, Capan G, Ergenc N, Rollas S . Synthesis, characterization and biological evaluation of new benzylidenebenzohydrazides and 2,5-disubstituted2,3-dihydro-1,3,4-oxadiazoles. Pharmazie. 1993; 48(12):942-3. View

17.

Kucukguzel S, Kucukguzel I, Ulgen M . Metabolic and chemical studies on N-(4-chlorobenzyl)-N'-benzoylhydrazine. Farmaco. 2001; 55(9-10):624-30. DOI: 10.1016/s0014-827x(00)00077-x. View

18.

Scior T, Garces-Eisele S . Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review. Curr Med Chem. 2006; 13(18):2205-19. DOI: 10.2174/092986706777935249. View

19.

BAVIN E, DRAIN D, Seiler M, SEYMOUR D . Some further studies on tuberculostatic compounds. J Pharm Pharmacol. 1952; 4(11):844-55. DOI: 10.1111/j.2042-7158.1952.tb13218.x. View

20.

Gursoy A, Karali N . Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinones. Eur J Med Chem. 2003; 38(6):633-43. DOI: 10.1016/s0223-5234(03)00085-0. View